article thumbnail

HHS Scores Early Win In Boehringer's Medicare Pricing Suit

Government Contracts

Department of Health and Human Services in Boehringer Ingelheim's challenge to a new Medicare drug price negotiation program, rejecting the pharmaceutical company's claim that the program is unconstitutional. A Connecticut federal judge on Wednesday sided with the U.S.

Price 98
article thumbnail

Government Contracts Cost and Pricing: The Truth in Negotiations Act, or Whatever the Kids Are Calling It These Days (Part 3)

Government Contracts & Investigations

Welcome back to the Cost Corner, where we provide practical insight into the complex cost and pricing requirements that apply to Government Contractors. We just completed two articles on the Truth in Negotiations Act (TINA) [1] and, before that, two articles on Defense Contract Audit Agency (DCAA) audits.

article thumbnail

Boehringer Appeals HHS Win In Medicare Drug Price Suit

Government Contracts

notified a Connecticut federal court Friday that it will appeal its loss in a lawsuit challenging a new Medicare drug price negotiation program on the grounds that it unlawfully compels the pharmaceutical giant to declare prices "fair," takes its property and imposes an excessive fine. Boehringer Ingelheim Pharmaceuticals Inc.

Price 52
article thumbnail

HHS Drug Pricing Program Flouts Constitution, Boehringer Says

Government Contracts

An "unprecedented" new Medicare price negotiation program deprives drugmakers of their constitutional rights and forces them to make declarations on issues of public concern that reflect poorly on them, Boehringer Ingelheim Pharmaceuticals Inc.

Price 52
article thumbnail

AstraZeneca Criticizes HHS For Bid To Skirt Drug Price Suit

Government Contracts

AstraZeneca has chided the federal government for seeking a quick win against the drugmaker's challenge to the Medicare drug price negotiation program in a recent brief, arguing that the Centers for Medicare and Medicaid Services mistakenly believes it has "absolute authority to unilaterally dictate prices."

Price 52
article thumbnail

The nexus between data management tools, transparency and procurement policy

Federal News Network

Data management tools, like pricing algorithms and artificial intelligence (AI), are playing an ever-larger role in Federal procurement as agencies look to streamline processes, increase efficiency, and improve contract outcomes. GSA’s current use of algorithms and pricing data is instructive in this regard.

article thumbnail

HHS Seeks Early Win Defending Medicare Drug Price Program

Government Contracts

Boehringer Ingelheim and other drugmakers are free to take their business elsewhere if they object to the new Medicare price negotiation program, the federal government has said, urging a judge to reject the company's claims of constitutional violations.

Price 52